Clinical Papers - Thursday, September 6

This session highlights the best submissions for clinical paper presentations as selected by the review committee.

Best Papers Session

2:15 - 2:55 PM - Scientific Session
Location: Grand Ballroom - Hyatt Regency Convention Center
Moderator: Kevin C. Chung, MD, MS, Steven L. Moran, MD

2:15 - 2:21 PM	Paper 01 Prospective international multi-centre series of 215 last generation total wrist arthroplasties. Preliminary results.	♦ Guillaume Herzberg, MD, PhD Michel E. H. Boeckstyns, MD, PhD
2:21 – 2:23 PM	Discussion / Rebuttal
2:23 - 2:29 PM	Paper 02 Postoperative Follow-up of Severe Carpal Tunnel Syndrome: Does Thumb Opposition Recover?	♦ Tatsuki Ebata, MD Susumu Tokunaga, MD Yuji Takahashi, MD Yoshihiro Abe, MD
2:29 – 2:31 PM	Discussion / Rebuttal
2:31 - 2:37 PM	Paper 03 A Long-term Multi-center Outcomes Study of Silicone Metacarpophalangeal Joint Arthroplasty in Rheumatoid Arthritis	♦ Kevin C. Chung, MD, MS Jennifer F. Waljee, MD, MS Patricia B. Burns, MPH Hyungjin M. Kim, ScD Frank D. Burke, MD E.F. Shaw Wilgis, MD
2:37 – 2:39 PM	Discussion / Rebuttal
2:39 - 2:45 PM	Paper 04 "Supercharge" Nerve Transfer to Enhance Motor Recovery	♦ Scott J. Farber, MD Simone Glaus, MD Ying Yan, MD, PhD Daniel Hunter, RA Philip J. Johnson, PhD Susan E. Mackinnon, MD
2:45 – 2:47 PM	Discussion / Rebuttal
2:47 - 2:53 PM	Paper 05 A summary of the functional outcomes following transplantation of 8 hands/upper extremities in 5 patients with an innovative cell based single drug immunotherapy protocol. ▲	♦ Jaimie T. Shores, MD Gerald Brandacher, MD Vijay Gorantla, MD Stefan Schneeberger, MD Joseph Losee, MD W.P. Andrew Lee, MD
2:53 – 2:55 PM	Discussion / Rebuttal

▲ Best Papers Session - Paper 05: A Summary of the Functional Outcomes Following Transplantation of 8 Hands/Upper Extremities in 5 Patients with an Innovative Cell Based Single Drug Immunotherapy Protocol will include discussion of Prograf (Tacnolimus), an "off-label" or other non-FDA approved, investigational pharmaceutical product manufactured by Stellas Pharma US.

View faculty disclosures here.